Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria

BACKGROUND: Hydroxyurea is underutilized by sickle cell health-care providers in Nigeria despite available evidence of its effectiveness in reducing the manifestations and complications of sickle cell disease (SCD). OBJECTIVES: To assess the level of utilization and provider-related barriers to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ofakunrin, Akinyemi OD, Okpe, Edache S, Afolaranmi, Tolulope O, Olaosebikan, Rasaq R, Kanhu, Patience U, Adekola, Kehinde, Dami, Nantok, Sagay, Atiene S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568227/
https://www.ncbi.nlm.nih.gov/pubmed/34795734
http://dx.doi.org/10.4314/ahs.v21i2.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568227/
https://www.ncbi.nlm.nih.gov/pubmed/34795734
http://dx.doi.org/10.4314/ahs.v21i2.36

Ejemplares similares